# Vicept Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vicept-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Malvern, US
- Total disclosed funding: $10M
- Latest round: Series A (Jun 30, 2010)
- Investors on record: 3

## About

Based in US, Vicept is a biopharmaceutical company focused on the development of the first effective topically-applied treatment for the skin redness associated with rosacea, and pursuing additional indications that include the treatment and prevention of actinic (solar) purpura and peri-procedural bruising of the skin.

## Funding rounds

- Series A, Jun 30, 2010, $10M — Sofinnova Investments, Vivo Capital, F-Prime Capital

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A